verbatim): The angiotensin II type 2 (AT2) receptor predominates in the left ventricle (LV) in hypertrophy and heart failure, and AT2 receptor activation suppresses growth and promotes apoptosis in vitro. This project will test the overall hypothesis that AT2 receptor signaling in vivo mediates anti-growth and pro-apoptotic effects in pressure overload hypertrophy. We will use transgenic mice with ventricular targeted overexpression of the AT2 receptor driven by the MLC2V promoter which are subjected to ascending aortic stenosis. Functional consequences will be studied by echocardiography and hemodynamic measurements, analysis of isolated myocyte contraction and intracellular ion regulation using fluorescence video microscopy, and confocal microscopy analysis of in situ cell morphology and apoptosis. Signaling pathways will be studied by immunohistochemistry and immunoblotting using antibodies to specific signaling molecules and identification of phosphorylation state.
The Specific Aims are:
Aim 1. To determine if AT2 receptor overexpression in transgenic mice suppresses in vivo hypertrophic growth in response to chronic systolic pressure overload from aortic stenosis. We predict that AT2 receptor overexpression severely depresses the development of LV hypertrophy, and promotes the rapid development of heart failure and premature death.
Aim 2. To test the hypothesis that AT2 receptor overexpression promotes myocyte apoptosis in mice with pressure overload. Apoptosis will be identified by in situ Tunel and ligase assays using confocal microscopy, and complementary measurement of cytochrome c leakage to the cytosol.
Aim 3. To determine if AT2 receptor overexpression in vivo modifies myocyte contractile function, and interferes with Ang II mediated inotropy. These experiments will employ measurements of contractility as well as intracellular pH and Ca2+ in isolated mouse myocytes, and test the hypothesis that AT2 receptor activation suppresses the coupling of Ang II with forward Na+-H+ exchange.
Aim 4. To determine if AT2 receptor overexpression in vivo activates the kinin-cGMP pathway. In vitro studies suggest that this system contributes to AT2 receptor signaling, but its contribution, if any, in the adult heart is not understood. Measurements will be made of cGMP levels and kininogenase activation in LV tissues (and atrial tissues in which the transgene is minimally expressed). In addition, the functional effects of inhibition of this pathway on cardiac growth and hemodynamic performance will be tested in vivo in mice with AT2 overexpression, in presence and absence of pressure overload. These integrated molecular physiology studies, which examine in vivo and cellular cardiac physiology, will provide new insights regarding cardioprotective versus deleterious effects of AT2 receptor activation in hypertrophy and heart failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL052864-06A1
Application #
6326229
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Liang, Isabella Y
Project Start
1995-06-01
Project End
2005-07-31
Budget Start
2001-03-16
Budget End
2002-07-31
Support Year
6
Fiscal Year
2001
Total Cost
$405,137
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Sun, Maoyun; Yan, Xinhua; Bian, Yun et al. (2011) Improving murine embryonic stem cell differentiation into cardiomyocytes with neuregulin-1: differential expression of microRNA. Am J Physiol Cell Physiol 301:C21-30
Bian, Yun; Sun, Maoyun; Silver, Marcy et al. (2009) Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins. Am J Physiol Heart Circ Physiol 297:H1974-83
Liu, Fen-Fen; Stone, James R; Schuldt, Adam J T et al. (2005) Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure. Am J Physiol Heart Circ Physiol 289:H660-6
Nascimben, Luigino; Ingwall, Joanne S; Lorell, Beverly H et al. (2004) Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertension 44:662-7
Eggleton, C D; Vadapalli, A; Roy, T K et al. (2000) Calculations of intracapillary oxygen tension distributions in muscle. Math Biosci 167:123-43
Weinberg, E O; Thienelt, C D; Katz, S E et al. (1999) Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 34:264-73
Eggleton, C D; Roy, T K; Popel, A S (1998) Predictions of capillary oxygen transport in the presence of fluorocarbon additives. Am J Physiol 275:H2250-7
Douglas, P S; Katz, S E; Weinberg, E O et al. (1998) Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol 32:1118-25
Weinberg, E O; Lee, M A; Weigner, M et al. (1997) Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis. Circulation 95:1592-600
Schunkert, H; Weinberg, E O; Bruckschlegel, G et al. (1995) Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J Clin Invest 96:2768-74